Abstract
ObjectiveDue to a high efficacy in clinical trials, sofosbuvir (SOF) and ribavirin (RBV) for 12 or 16 weeks is recommended for treatment of patients with HCV genotype (GT) 2 infection....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have